$13.55
-0.05-0.37%
At close: -
$14.81
1.269.30%
After Hours: 5:13 PM EDT
Comments
Loading...
KalVista Pharma Earnings Estimates, EPS & Revenue | NASDAQ:KALV | Benzinga
KalVista Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Jul 10
EPS Estimate
$-0.920
Quarterly Revenue Estimate
–
Annual Revenue
(as of Jan 31)
(as of Jan 31)
–
Analyze the earnings history of KalVista Pharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KALV | KalVista Pharma | -$1.02 | -$0.92 | — | — | $0.00 | — | — | — | 07/10/2025 | Get Alert |
| KALV | KalVista Pharma | -$0.84 | -$0.88 | -$0.92 | -4.55% | $0.00 | — | $0.00 | — | 03/12/2025 | Get Alert |
| KALV | KalVista Pharma | -$0.80 | -$0.91 | -$0.91 | 0.00% | $0.00 | — | $0.00 | — | 12/05/2024 | Get Alert |
| KALV | KalVista Pharma | -$0.74 | -$0.86 | -$0.87 | -1.16% | $0.00 | — | $0.00 | — | 09/05/2024 | Get Alert |
| KALV | KalVista Pharma | -$0.77 | -$0.73 | -$1.02 | -39.73% | $0.00 | — | $0.00 | — | 07/11/2024 | Get Alert |
| KALV | KalVista Pharma | -$0.75 | -$0.77 | -$0.84 | -9.09% | $0.00 | — | $0.00 | — | 03/11/2024 | Get Alert |
| KALV | KalVista Pharma | -$0.90 | -$0.79 | -$0.80 | -1.27% | $0.00 | — | $0.00 | — | 12/07/2023 | Get Alert |
| KALV | KalVista Pharma | -$0.94 | -$0.86 | -$0.74 | 1395.35% | $0.00 | — | $0.00 | — | 09/07/2023 | Get Alert |
| KALV | KalVista Pharma | -$0.98 | -$0.94 | -$0.77 | 18.09% | $0.00 | — | $0.00 | — | 07/07/2023 | Get Alert |
| KALV | KalVista Pharma | -$0.92 | -$0.98 | -$0.75 | 23.47% | $0.00 | — | $0.00 | — | 03/09/2023 | Get Alert |
| KALV | KalVista Pharma | -$0.80 | -$1.06 | -$0.90 | 15.09% | $0.00 | — | $0.00 | — | 12/08/2022 | Get Alert |
| KALV | KalVista Pharma | -$0.66 | -$1.04 | -$0.94 | 9.62% | $0.00 | — | $0.00 | — | 09/08/2022 | Get Alert |
| KALV | KalVista Pharma | -$0.65 | -$1.09 | -$0.98 | 10.09% | $0.00 | — | $0.00 | — | 07/07/2022 | Get Alert |
| KALV | KalVista Pharma | -$0.56 | -$0.93 | -$0.92 | 1.08% | $0.00 | — | $0.00 | — | 03/10/2022 | Get Alert |
| KALV | KalVista Pharma | -$0.58 | -$0.79 | -$0.80 | -1.27% | $0.00 | — | $0.00 | — | 12/09/2021 | Get Alert |
| KALV | KalVista Pharma | -$0.61 | -$0.71 | -$0.66 | 7.04% | $0.00 | — | $0.00 | — | 09/09/2021 | Get Alert |
| KALV | KalVista Pharma | -$0.37 | -$0.56 | -$0.65 | -16.07% | $3.82M | $580.00K | $0.00 | -100.00% | 07/13/2021 | Get Alert |
| KALV | KalVista Pharma | -$0.52 | — | -$0.56 | — | $1.58M | — | $0.00 | — | 03/11/2021 | Get Alert |
| KALV | KalVista Pharma | -$0.33 | — | -$0.58 | — | $3.92M | — | $0.00 | — | 12/10/2020 | Get Alert |
| KALV | KalVista Pharma | -$0.42 | — | -$0.61 | — | $3.37M | — | $0.00 | — | 09/14/2020 | Get Alert |
| KALV | KalVista Pharma | -$0.49 | — | -$0.37 | — | $2.93M | — | $3.82M | — | 07/01/2020 | Get Alert |
KalVista Pharma (KALV) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-03-12 | $-0.92 | $-0.88 | -4.55 % |
| Q2 | 2024-12-05 | $-0.91 | $-0.91 | 0.00 % |
| Q1 | 2024-09-05 | $-0.87 | $-0.86 | -1.16 % |
| Q4 | 2024-07-11 | $-1.02 | $-0.73 | -39.7 % |
KalVista Pharma (KALV) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2021-07-13 | $0 | $580.00K | -100.0 % |
FAQ
When is KalVista Pharma (NASDAQ:KALV) reporting earnings?
KalVista Pharma (KALV) is scheduled to report earnings on July 10, 2025. The last reported earnings were for reported on March 12, 2025 for Q3.
What were the latest earnings per share (EPS) for KalVista Pharma (NASDAQ:KALV)?
The Actual EPS was $-0.92, which missed the estimate of $-0.88.
What were KalVista Pharma’s (NASDAQ:KALV) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
